Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysis

Chee Khoon Lee, Clare L. Scott, Angelina Tjokrowidjaja et al.|Cancer|2021

Cited by 37